APO Research
Talk to an analyst

APO RESEARCH · REPORT

HER2 ADC Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global HER2 ADC Drugs Market Analysis and Forecast 2026-2032

27 December 2025199 pages

Choose your research edition.

Industry ResearchHER2 ADC Drugs Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal HER2 ADC Drugs Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal HER2 ADC Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HER2 ADC Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal HER2 ADC Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global HER2 ADC Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for HER2 ADC Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for HER2 ADC Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for HER2 ADC Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for HER2 ADC Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of HER2 ADC Drugs include CSPC Pharmaceutical Group, Hengrui Pharmaceuticals, BioNTech(Yingen Biopharmaceutical), Biokin Pharmaceutical, Takeda, RemeGen, MacroGenics, Genentech, Inc.(Roche) and Daiichi Sankyo, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for HER2 ADC Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of HER2 ADC Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for HER2 ADC Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the HER2 ADC Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global HER2 ADC Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for HER2 ADC Drugs sales, projected growth trends, production technology, application and end-user industry.

HER2 ADC Drugs Segment by Company

CSPC Pharmaceutical Group

Hengrui Pharmaceuticals

BioNTech(Yingen Biopharmaceutical)

Biokin Pharmaceutical

Takeda

RemeGen

MacroGenics

Genentech, Inc.(Roche)

Daiichi Sankyo

AstraZeneca

HER2 ADC Drugs Segment by Type

RC48（Disitamab vedotin）

T-DM1（Kadcyla，Trastuzumab emtansine）

T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）

HER2 ADC Drugs Segment by Application

Hospitals

Clinic

Others

HER2 ADC Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HER2 ADC Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HER2 ADC Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HER2 ADC Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of HER2 ADC Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of HER2 ADC Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HER2 ADC Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global HER2 ADC Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. RC48（Disitamab vedotin） Major Manufacturers Table 3. T-DM1（Kadcyla，Trastuzumab emtansine） Major Manufacturers Table 4. T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan） Major Manufacturers Table 5. Global HER2 ADC Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Others Major Manufacturers Table 9. HER2 ADC Drugs Industry Trends Table 10. HER2 ADC Drugs Industry Drivers Table 11. HER2 ADC Drugs Industry Opportunities and Challenges Table 12. HER2 ADC Drugs Industry Restraints Table 13. Global HER2 ADC Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global HER2 ADC Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global HER2 ADC Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global HER2 ADC Drugs Revenue Market Share by Region (2021-2026) Table 17. Global HER2 ADC Drugs Revenue Market Share by Region (2027-2032) Table 18. Global HER2 ADC Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K G) Table 19. Global HER2 ADC Drugs Sales by Region (2021-2026) & (K G) Table 20. Global HER2 ADC Drugs Sales by Region (2027-2032) & (K G) Table 21. Global HER2 ADC Drugs Sales Market Share by Region (2021-2026) Table 22. Global HER2 ADC Drugs Sales Market Share by Region (2027-2032) Table 23. Global HER2 ADC Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global HER2 ADC Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global HER2 ADC Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global HER2 ADC Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global HER2 ADC Drugs Sales Price (US$/K G) of Manufacturers (2021-2026) Table 28. Global HER2 ADC Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global HER2 ADC Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global HER2 ADC Drugs Manufacturers, Product Type & Application Table 31. Global HER2 ADC Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global HER2 ADC Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global HER2 ADC Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global HER2 ADC Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global HER2 ADC Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global HER2 ADC Drugs Revenue Market Share by Type (2021-2026) Table 38. Global HER2 ADC Drugs Revenue Market Share by Type (2027-2032) Table 39. Global HER2 ADC Drugs Sales by Type 2021 VS 2025 VS 2032 (K G) Table 40. Global HER2 ADC Drugs Sales by Type (2021-2026) & (K G) Table 41. Global HER2 ADC Drugs Sales by Type (2027-2032) & (K G) Table 42. Global HER2 ADC Drugs Sales Market Share by Type (2021-2026) Table 43. Global HER2 ADC Drugs Sales Market Share by Type (2027-2032) Table 44. Global HER2 ADC Drugs Price by Type (2021-2026) & (US$/K G) Table 45. Global HER2 ADC Drugs Price by Type (2027-2032) & (US$/K G) Table 46. Global HER2 ADC Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global HER2 ADC Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global HER2 ADC Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global HER2 ADC Drugs Revenue Market Share by Application (2021-2026) Table 50. Global HER2 ADC Drugs Revenue Market Share by Application (2027-2032) Table 51. Global HER2 ADC Drugs Sales by Application 2021 VS 2025 VS 2032 (K G) Table 52. Global HER2 ADC Drugs Sales by Application (2021-2026) & (K G) Table 53. Global HER2 ADC Drugs Sales by Application (2027-2032) & (K G) Table 54. Global HER2 ADC Drugs Sales Market Share by Application (2021-2026) Table 55. Global HER2 ADC Drugs Sales Market Share by Application (2027-2032) Table 56. Global HER2 ADC Drugs Price by Application (2021-2026) & (US$/K G) Table 57. Global HER2 ADC Drugs Price by Application (2027-2032) & (US$/K G) Table 58. CSPC Pharmaceutical Group Company Information Table 59. CSPC Pharmaceutical Group Business Overview Table 60. CSPC Pharmaceutical Group HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 61. CSPC Pharmaceutical Group HER2 ADC Drugs Product Portfolio Table 62. CSPC Pharmaceutical Group Recent Development Table 63. Hengrui Pharmaceuticals Company Information Table 64. Hengrui Pharmaceuticals Business Overview Table 65. Hengrui Pharmaceuticals HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 66. Hengrui Pharmaceuticals HER2 ADC Drugs Product Portfolio Table 67. Hengrui Pharmaceuticals Recent Development Table 68. BioNTech(Yingen Biopharmaceutical) Company Information Table 69. BioNTech(Yingen Biopharmaceutical) Business Overview Table 70. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 71. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product Portfolio Table 72. BioNTech(Yingen Biopharmaceutical) Recent Development Table 73. Biokin Pharmaceutical Company Information Table 74. Biokin Pharmaceutical Business Overview Table 75. Biokin Pharmaceutical HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 76. Biokin Pharmaceutical HER2 ADC Drugs Product Portfolio Table 77. Biokin Pharmaceutical Recent Development Table 78. Takeda Company Information Table 79. Takeda Business Overview Table 80. Takeda HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 81. Takeda HER2 ADC Drugs Product Portfolio Table 82. Takeda Recent Development Table 83. RemeGen Company Information Table 84. RemeGen Business Overview Table 85. RemeGen HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 86. RemeGen HER2 ADC Drugs Product Portfolio Table 87. RemeGen Recent Development Table 88. MacroGenics Company Information Table 89. MacroGenics Business Overview Table 90. MacroGenics HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 91. MacroGenics HER2 ADC Drugs Product Portfolio Table 92. MacroGenics Recent Development Table 93. Genentech, Inc.(Roche) Company Information Table 94. Genentech, Inc.(Roche) Business Overview Table 95. Genentech, Inc.(Roche) HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 96. Genentech, Inc.(Roche) HER2 ADC Drugs Product Portfolio Table 97. Genentech, Inc.(Roche) Recent Development Table 98. Daiichi Sankyo Company Information Table 99. Daiichi Sankyo Business Overview Table 100. Daiichi Sankyo HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 101. Daiichi Sankyo HER2 ADC Drugs Product Portfolio Table 102. Daiichi Sankyo Recent Development Table 103. AstraZeneca Company Information Table 104. AstraZeneca Business Overview Table 105. AstraZeneca HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 106. AstraZeneca HER2 ADC Drugs Product Portfolio Table 107. AstraZeneca Recent Development Table 108. North America HER2 ADC Drugs Revenue by Type (2021-2026) & (US$ Million) Table 109. North America HER2 ADC Drugs Revenue by Type (2027-2032) & (US$ Million) Table 110. North America HER2 ADC Drugs Sales by Type (2021-2026) & (K G) Table 111. North America HER2 ADC Drugs Sales by Type (2027-2032) & (K G) Table 112. North America HER2 ADC Drugs Sales Price by Type (2021-2026) & (US$/K G) Table 113. North America HER2 ADC Drugs Sales Price by Type (2027-2032) & (US$/K G) Table 114. North America HER2 ADC Drugs Revenue by Application (2021-2026) & (US$ Million) Table 115. North America HER2 ADC Drugs Revenue by Application (2027-2032) & (US$ Million) Table 116. North America HER2 ADC Drugs Sales by Application (2021-2026) & (K G) Table 117. North America HER2 ADC Drugs Sales by Application (2027-2032) & (K G) Table 118. North America HER2 ADC Drugs Sales Price by Application (2021-2026) & (US$/K G) Table 119. North America HER2 ADC Drugs Sales Price by Application (2027-2032) & (US$/K G) Table 120. North America HER2 ADC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America HER2 ADC Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America HER2 ADC Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America HER2 ADC Drugs Sales by Country (2021 VS 2025 VS 2032) & (K G) Table 124. North America HER2 ADC Drugs Sales by Country (2021-2026) & (K G) Table 125. North America HER2 ADC Drugs Sales by Country (2027-2032) & (K G) Table 126. North America HER2 ADC Drugs Sales Price by Country (2021-2026) & (US$/K G) Table 127. North America HER2 ADC Drugs Sales Price by Country (2027-2032) & (US$/K G) Table 128. United States HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 129. Canada HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 130. Mexico HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 131. Europe HER2 ADC Drugs Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe HER2 ADC Drugs Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe HER2 ADC Drugs Sales by Type (2021-2026) & (K G) Table 134. Europe HER2 ADC Drugs Sales by Type (2027-2032) & (K G) Table 135. Europe HER2 ADC Drugs Sales Price by Type (2021-2026) & (US$/K G) Table 136. Europe HER2 ADC Drugs Sales Price by Type (2027-2032) & (US$/K G) Table 137. Europe HER2 ADC Drugs Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe HER2 ADC Drugs Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe HER2 ADC Drugs Sales by Application (2021-2026) & (K G) Table 140. Europe HER2 ADC Drugs Sales by Application (2027-2032) & (K G) Table 141. Europe HER2 ADC Drugs Sales Price by Application (2021-2026) & (US$/K G) Table 142. Europe HER2 ADC Drugs Sales Price by Application (2027-2032) & (US$/K G) Table 143. Europe HER2 ADC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe HER2 ADC Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe HER2 ADC Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe HER2 ADC Drugs Sales by Country (2021 VS 2025 VS 2032) & (K G) Table 147. Europe HER2 ADC Drugs Sales by Country (2021-2026) & (K G) Table 148. Europe HER2 ADC Drugs Sales by Country (2027-2032) & (K G) Table 149. Europe HER2 ADC Drugs Sales Price by Country (2021-2026) & (US$/K G) Table 150. Europe HER2 ADC Drugs Sales Price by Country (2027-2032) & (US$/K G) Table 151. Germany HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 152. France HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 153. U.K. HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 154. Italy HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 155. Russia HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 156. Spain HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 157. Netherlands HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 158. Switzerland HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 159. Sweden HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 160. Poland HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 161. China HER2 ADC Drugs Revenue by Type (2021-2026) & (US$ Million) Table 162. China HER2 ADC Drugs Revenue by Type (2027-2032) & (US$ Million) Table 163. China HER2 ADC Drugs Sales by Type (2021-2026) & (K G) Table 164. China HER2 ADC Drugs Sales by Type (2027-2032) & (K G) Table 165. China HER2 ADC Drugs Sales Price by Type (2021-2026) & (US$/K G) Table 166. China HER2 ADC Drugs Sales Price by Type (2027-2032) & (US$/K G) Table 167. China HER2 ADC Drugs Revenue by Application (2021-2026) & (US$ Million) Table 168. China HER2 ADC Drugs Revenue by Application (2027-2032) & (US$ Million) Table 169. China HER2 ADC Drugs Sales by Application (2021-2026) & (K G) Table 170. China HER2 ADC Drugs Sales by Application (2027-2032) & (K G) Table 171. China HER2 ADC Drugs Sales Price by Application (2021-2026) & (US$/K G) Table 172. China HER2 ADC Drugs Sales Price by Application (2027-2032) & (US$/K G) Table 173. Asia HER2 ADC Drugs Revenue by Type (2021-2026) & (US$ Million) Table 174. Asia HER2 ADC Drugs Revenue by Type (2027-2032) & (US$ Million) Table 175. Asia HER2 ADC Drugs Sales by Type (2021-2026) & (K G) Table 176. Asia HER2 ADC Drugs Sales by Type (2027-2032) & (K G) Table 177. Asia HER2 ADC Drugs Sales Price by Type (2021-2026) & (US$/K G) Table 178. Asia HER2 ADC Drugs Sales Price by Type (2027-2032) & (US$/K G) Table 179. Asia HER2 ADC Drugs Revenue by Application (2021-2026) & (US$ Million) Table 180. Asia HER2 ADC Drugs Revenue by Application (2027-2032) & (US$ Million) Table 181. Asia HER2 ADC Drugs Sales by Application (2021-2026) & (K G) Table 182. Asia HER2 ADC Drugs Sales by Application (2027-2032) & (K G) Table 183. Asia HER2 ADC Drugs Sales Price by Application (2021-2026) & (US$/K G) Table 184. Asia HER2 ADC Drugs Sales Price by Application (2027-2032) & (US$/K G) Table 185. Asia HER2 ADC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Asia HER2 ADC Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. Asia HER2 ADC Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. Asia HER2 ADC Drugs Sales by Country (2021 VS 2025 VS 2032) & (K G) Table 189. Asia HER2 ADC Drugs Sales by Country (2021-2026) & (K G) Table 190. Asia HER2 ADC Drugs Sales by Country (2027-2032) & (K G) Table 191. Asia HER2 ADC Drugs Sales Price by Country (2021-2026) & (US$/K G) Table 192. Asia HER2 ADC Drugs Sales Price by Country (2027-2032) & (US$/K G) Table 193. Japan HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 194. South Korea HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 195. India HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 196. Australia HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 197. Taiwan HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 198. Southeast Asia HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 199. SAMEA HER2 ADC Drugs Revenue by Type (2021-2026) & (US$ Million) Table 200. SAMEA HER2 ADC Drugs Revenue by Type (2027-2032) & (US$ Million) Table 201. SAMEA HER2 ADC Drugs Sales by Type (2021-2026) & (K G) Table 202. SAMEA HER2 ADC Drugs Sales by Type (2027-2032) & (K G) Table 203. SAMEA HER2 ADC Drugs Sales Price by Type (2021-2026) & (US$/K G) Table 204. SAMEA HER2 ADC Drugs Sales Price by Type (2027-2032) & (US$/K G) Table 205. SAMEA HER2 ADC Drugs Revenue by Application (2021-2026) & (US$ Million) Table 206. SAMEA HER2 ADC Drugs Revenue by Application (2027-2032) & (US$ Million) Table 207. SAMEA HER2 ADC Drugs Sales by Application (2021-2026) & (K G) Table 208. SAMEA HER2 ADC Drugs Sales by Application (2027-2032) & (K G) Table 209. SAMEA HER2 ADC Drugs Sales Price by Application (2021-2026) & (US$/K G) Table 210. SAMEA HER2 ADC Drugs Sales Price by Application (2027-2032) & (US$/K G) Table 211. SAMEA HER2 ADC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. SAMEA HER2 ADC Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. SAMEA HER2 ADC Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. SAMEA HER2 ADC Drugs Sales by Country (2021 VS 2025 VS 2032) & (K G) Table 215. SAMEA HER2 ADC Drugs Sales by Country (2021-2026) & (K G) Table 216. SAMEA HER2 ADC Drugs Sales by Country (2027-2032) & (K G) Table 217. SAMEA HER2 ADC Drugs Sales Price by Country (2021-2026) & (US$/K G) Table 218. SAMEA HER2 ADC Drugs Sales Price by Country (2027-2032) & (US$/K G) Table 219. Brazil HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 220. Argentina HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 221. Chile HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 222. Colombia HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 223. Peru HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 224. Saudi Arabia HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 225. Israel HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 226. UAE HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 227. Turkey HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 228. Iran HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 229. Egypt HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Table 230. Key Raw Materials Table 231. Raw Materials Key Suppliers Table 232. HER2 ADC Drugs Distributors List Table 233. HER2 ADC Drugs Customers List Table 234. Research Programs/Design for This Report Table 235. Authors List of This Report Table 236. Secondary Sources Table 237. Primary Sources List of Figures Figure 1. HER2 ADC Drugs Image Figure 2. Global HER2 ADC Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HER2 ADC Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. RC48（Disitamab vedotin） Image Figure 5. T-DM1（Kadcyla，Trastuzumab emtansine） Image Figure 6. T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan） Image Figure 7. Global HER2 ADC Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global HER2 ADC Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Clinic Image Figure 11. Others Image Figure 12. Global HER2 ADC Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global HER2 ADC Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global HER2 ADC Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global HER2 ADC Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global HER2 ADC Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global HER2 ADC Drugs Sales (2021-2032) & (K G) Figure 18. Global HER2 ADC Drugs Sales by Region: 2021 VS 2025 VS 2032 (K G) Figure 19. Global HER2 ADC Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico HER2 ADC Drugs Sales YoY (2021-2032) & (K G) Figure 21. Europe HER2 ADC Drugs Sales YoY (2021-2032) & (K G) Figure 22. China HER2 ADC Drugs Sales YoY (2021-2032) & (K G) Figure 23. Asia (Excluding China) HER2 ADC Drugs Sales YoY (2021-2032) & (K G) Figure 24. South America, Middle East and Africa HER2 ADC Drugs Sales YoY (2021-2032) & (K G) Figure 25. Global HER2 ADC Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global HER2 ADC Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global HER2 ADC Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global HER2 ADC Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global HER2 ADC Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global HER2 ADC Drugs Sales by Type (2021 VS 2025 VS 2032) & (K G) Figure 32. Global HER2 ADC Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global HER2 ADC Drugs Sales Market Share by Type (2021-2032) Figure 34. Global HER2 ADC Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global HER2 ADC Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global HER2 ADC Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global HER2 ADC Drugs Sales by Application (2021 VS 2025 VS 2032) & (K G) Figure 38. Global HER2 ADC Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global HER2 ADC Drugs Sales Market Share by Application (2021-2032) Figure 40. North America HER2 ADC Drugs Revenue Share by Type (2021-2032) Figure 41. North America HER2 ADC Drugs Sales Share by Type (2021-2032) Figure 42. North America HER2 ADC Drugs Revenue Share by Application (2021-2032) Figure 43. North America HER2 ADC Drugs Sales Share by Application (2021-2032) Figure 44. North America HER2 ADC Drugs Revenue Share by Country (2021-2032) Figure 45. North America HER2 ADC Drugs Sales Share by Country (2021-2032) Figure 46. Europe HER2 ADC Drugs Revenue Share by Type (2021-2032) Figure 47. Europe HER2 ADC Drugs Sales Share by Type (2021-2032) Figure 48. Europe HER2 ADC Drugs Revenue Share by Application (2021-2032) Figure 49. Europe HER2 ADC Drugs Sales Share by Application (2021-2032) Figure 50. Europe HER2 ADC Drugs Revenue Share by Country (2021-2032) Figure 51. Europe HER2 ADC Drugs Sales Share by Country (2021-2032) Figure 52. China HER2 ADC Drugs Revenue Share by Type (2021-2032) Figure 53. China HER2 ADC Drugs Sales Share by Type (2021-2032) Figure 54. China HER2 ADC Drugs Revenue Share by Application (2021-2032) Figure 55. China HER2 ADC Drugs Sales Share by Application (2021-2032) Figure 56. Asia HER2 ADC Drugs Revenue Share by Type (2021-2032) Figure 57. Asia HER2 ADC Drugs Sales Share by Type (2021-2032) Figure 58. Asia HER2 ADC Drugs Revenue Share by Application (2021-2032) Figure 59. Asia HER2 ADC Drugs Sales Share by Application (2021-2032) Figure 60. Asia HER2 ADC Drugs Revenue Share by Country (2021-2032) Figure 61. Asia HER2 ADC Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA HER2 ADC Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA HER2 ADC Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA HER2 ADC Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA HER2 ADC Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA HER2 ADC Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA HER2 ADC Drugs Sales Share by Country (2021-2032) Figure 68. HER2 ADC Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. HER2 ADC Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • RC48（Disitamab vedotin）
  • T-DM1（Kadcyla，Trastuzumab emtansine）
  • T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）
Applications
  • Hospitals
  • Clinic
  • Others
Companies covered
  • CSPC Pharmaceutical Group
  • Hengrui Pharmaceuticals
  • BioNTech(Yingen Biopharmaceutical)
  • Biokin Pharmaceutical
  • Takeda
  • RemeGen
  • MacroGenics
  • Genentech, Inc.(Roche)
  • Daiichi Sankyo
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 HER2 ADC Drugs Market by Type
  3. 1.2.1 Global HER2 ADC Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 RC48（Disitamab vedotin）
  5. 1.2.3 T-DM1（Kadcyla，Trastuzumab emtansine）
  6. 1.2.4 T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）
  7. 1.3 HER2 ADC Drugs Market by Application
  8. 1.3.1 Global HER2 ADC Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Clinic
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 HER2 ADC Drugs Market Dynamics
  1. 2.1 HER2 ADC Drugs Industry Trends
  2. 2.2 HER2 ADC Drugs Industry Drivers
  3. 2.3 HER2 ADC Drugs Industry Opportunities and Challenges
  4. 2.4 HER2 ADC Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global HER2 ADC Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global HER2 ADC Drugs Revenue by Region
  3. 3.2.1 Global HER2 ADC Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global HER2 ADC Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global HER2 ADC Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global HER2 ADC Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global HER2 ADC Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global HER2 ADC Drugs Sales by Region
  9. 3.4.1 Global HER2 ADC Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global HER2 ADC Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global HER2 ADC Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global HER2 ADC Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global HER2 ADC Drugs Revenue by Manufacturers
  2. 4.1.1 Global HER2 ADC Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global HER2 ADC Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global HER2 ADC Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global HER2 ADC Drugs Sales by Manufacturers
  6. 4.2.1 Global HER2 ADC Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global HER2 ADC Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global HER2 ADC Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global HER2 ADC Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global HER2 ADC Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global HER2 ADC Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global HER2 ADC Drugs Manufacturers, Product Type & Application
  13. 4.7 Global HER2 ADC Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global HER2 ADC Drugs Market CR5 and HHI
  16. 4.8.2 2025 HER2 ADC Drugs Tier 1, Tier 2, and Tier 3
5 HER2 ADC Drugs Market by Type
  1. 5.1 Global HER2 ADC Drugs Revenue by Type
  2. 5.1.1 Global HER2 ADC Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global HER2 ADC Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global HER2 ADC Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global HER2 ADC Drugs Sales by Type
  6. 5.2.1 Global HER2 ADC Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global HER2 ADC Drugs Sales by Type (2021-2032) & (K G)
  8. 5.2.3 Global HER2 ADC Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global HER2 ADC Drugs Price by Type
6 HER2 ADC Drugs Market by Application
  1. 6.1 Global HER2 ADC Drugs Revenue by Application
  2. 6.1.1 Global HER2 ADC Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global HER2 ADC Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global HER2 ADC Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global HER2 ADC Drugs Sales by Application
  6. 6.2.1 Global HER2 ADC Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global HER2 ADC Drugs Sales by Application (2021-2032) & (K G)
  8. 6.2.3 Global HER2 ADC Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global HER2 ADC Drugs Price by Application
7 Company Profiles
  1. 7.1 CSPC Pharmaceutical Group
  2. 7.1.1 CSPC Pharmaceutical Group Company Information
  3. 7.1.2 CSPC Pharmaceutical Group Business Overview
  4. 7.1.3 CSPC Pharmaceutical Group HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CSPC Pharmaceutical Group HER2 ADC Drugs Product Portfolio
  6. 7.1.5 CSPC Pharmaceutical Group Recent Developments
  7. 7.2 Hengrui Pharmaceuticals
  8. 7.2.1 Hengrui Pharmaceuticals Company Information
  9. 7.2.2 Hengrui Pharmaceuticals Business Overview
  10. 7.2.3 Hengrui Pharmaceuticals HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Hengrui Pharmaceuticals HER2 ADC Drugs Product Portfolio
  12. 7.2.5 Hengrui Pharmaceuticals Recent Developments
  13. 7.3 BioNTech(Yingen Biopharmaceutical)
  14. 7.3.1 BioNTech(Yingen Biopharmaceutical) Company Information
  15. 7.3.2 BioNTech(Yingen Biopharmaceutical) Business Overview
  16. 7.3.3 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product Portfolio
  18. 7.3.5 BioNTech(Yingen Biopharmaceutical) Recent Developments
  19. 7.4 Biokin Pharmaceutical
  20. 7.4.1 Biokin Pharmaceutical Company Information
  21. 7.4.2 Biokin Pharmaceutical Business Overview
  22. 7.4.3 Biokin Pharmaceutical HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Biokin Pharmaceutical HER2 ADC Drugs Product Portfolio
  24. 7.4.5 Biokin Pharmaceutical Recent Developments
  25. 7.5 Takeda
  26. 7.5.1 Takeda Company Information
  27. 7.5.2 Takeda Business Overview
  28. 7.5.3 Takeda HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Takeda HER2 ADC Drugs Product Portfolio
  30. 7.5.5 Takeda Recent Developments
  31. 7.6 RemeGen
  32. 7.6.1 RemeGen Company Information
  33. 7.6.2 RemeGen Business Overview
  34. 7.6.3 RemeGen HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 RemeGen HER2 ADC Drugs Product Portfolio
  36. 7.6.5 RemeGen Recent Developments
  37. 7.7 MacroGenics
  38. 7.7.1 MacroGenics Company Information
  39. 7.7.2 MacroGenics Business Overview
  40. 7.7.3 MacroGenics HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 MacroGenics HER2 ADC Drugs Product Portfolio
  42. 7.7.5 MacroGenics Recent Developments
  43. 7.8 Genentech, Inc.(Roche)
  44. 7.8.1 Genentech, Inc.(Roche) Company Information
  45. 7.8.2 Genentech, Inc.(Roche) Business Overview
  46. 7.8.3 Genentech, Inc.(Roche) HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Genentech, Inc.(Roche) HER2 ADC Drugs Product Portfolio
  48. 7.8.5 Genentech, Inc.(Roche) Recent Developments
  49. 7.9 Daiichi Sankyo
  50. 7.9.1 Daiichi Sankyo Company Information
  51. 7.9.2 Daiichi Sankyo Business Overview
  52. 7.9.3 Daiichi Sankyo HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Daiichi Sankyo HER2 ADC Drugs Product Portfolio
  54. 7.9.5 Daiichi Sankyo Recent Developments
  55. 7.10 AstraZeneca
  56. 7.10.1 AstraZeneca Company Information
  57. 7.10.2 AstraZeneca Business Overview
  58. 7.10.3 AstraZeneca HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 AstraZeneca HER2 ADC Drugs Product Portfolio
  60. 7.10.5 AstraZeneca Recent Developments
8 North America
  1. 8.1 North America HER2 ADC Drugs Market Size by Type
  2. 8.1.1 North America HER2 ADC Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America HER2 ADC Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America HER2 ADC Drugs Price by Type (2021-2032)
  5. 8.2 North America HER2 ADC Drugs Market Size by Application
  6. 8.2.1 North America HER2 ADC Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America HER2 ADC Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America HER2 ADC Drugs Price by Application (2021-2032)
  9. 8.3 North America HER2 ADC Drugs Market Size by Country
  10. 8.3.1 North America HER2 ADC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America HER2 ADC Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America HER2 ADC Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe HER2 ADC Drugs Market Size by Type
  2. 9.1.1 Europe HER2 ADC Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe HER2 ADC Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe HER2 ADC Drugs Price by Type (2021-2032)
  5. 9.2 Europe HER2 ADC Drugs Market Size by Application
  6. 9.2.1 Europe HER2 ADC Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe HER2 ADC Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe HER2 ADC Drugs Price by Application (2021-2032)
  9. 9.3 Europe HER2 ADC Drugs Market Size by Country
  10. 9.3.1 Europe HER2 ADC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe HER2 ADC Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe HER2 ADC Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China HER2 ADC Drugs Market Size by Type
  2. 10.1.1 China HER2 ADC Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China HER2 ADC Drugs Sales by Type (2021-2032)
  4. 10.1.3 China HER2 ADC Drugs Price by Type (2021-2032)
  5. 10.2 China HER2 ADC Drugs Market Size by Application
  6. 10.2.1 China HER2 ADC Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China HER2 ADC Drugs Sales by Application (2021-2032)
  8. 10.2.3 China HER2 ADC Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia HER2 ADC Drugs Market Size by Type
  2. 11.1.1 Asia HER2 ADC Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia HER2 ADC Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia HER2 ADC Drugs Price by Type (2021-2032)
  5. 11.2 Asia HER2 ADC Drugs Market Size by Application
  6. 11.2.1 Asia HER2 ADC Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia HER2 ADC Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia HER2 ADC Drugs Price by Application (2021-2032)
  9. 11.3 Asia HER2 ADC Drugs Market Size by Country
  10. 11.3.1 Asia HER2 ADC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia HER2 ADC Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia HER2 ADC Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA HER2 ADC Drugs Market Size by Type
  2. 12.1.1 SAMEA HER2 ADC Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA HER2 ADC Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA HER2 ADC Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA HER2 ADC Drugs Market Size by Application
  6. 12.2.1 SAMEA HER2 ADC Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA HER2 ADC Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA HER2 ADC Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA HER2 ADC Drugs Market Size by Country
  10. 12.3.1 SAMEA HER2 ADC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA HER2 ADC Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA HER2 ADC Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 HER2 ADC Drugs Value Chain Analysis
  2. 13.1.1 HER2 ADC Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 HER2 ADC Drugs Production Mode & Process
  6. 13.2 HER2 ADC Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 HER2 ADC Drugs Distributors
  9. 13.2.3 HER2 ADC Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst